Literature DB >> 8632898

Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes.

Z P Ren1, A Hedrum, F Pontén, M Nistér, A Ahmadian, J Lundeberg, M Uhlén, J Pontén.   

Abstract

Microdissection of biopsies with sequencing of exons 4-8 of the p53 gene permitted precise morphological identification of correlation between mutations and/or loss of heterozygosity, immunoreactivty of p53 and type of squamous neoplasia. Seventy-two specimens from ten lesions of sun-exposed sites including normal epidermis were analysed. Irrespective of p53 immunoreactivity and morphological grade dysplasia, in situ or invasive cancer, in each case, carried the identical mutation indicating that invasive skin cancer and its precursors derive from the same original neoplastic clone. Additionally, morphologically normal epidermis showed some sharply demarcated immunoreactive areas. These never had the same p53 mutation as that of the adjacent tumor, indicating that their mutations were separate events and ruling them out as common precursors of cancer. Non-immunoreactive normal epidermis did not show p53 mutations. Our findings indicate that a large fraction of keratinocytes in sun-exposed human skin carry mutations of p53 and suggest that at least two options exist for such cells (i) innocuous clonal expansion with preserved morphology and normal differentiation or (ii) malignant transformation with the p53 mutation as an early event. Suggestive evidence existed that the p53 mutations were qualitatively different in the two respective groups of lesions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632898

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Persistent p53 mutations in single cells from normal human skin.

Authors:  G Ling; A Persson; B Berne; M Uhlén; J Lundeberg; F Ponten
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

2.  Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.

Authors:  J G Einspahr; D S Alberts; J A Warneke; P Bozzo; J Basye; T M Grogan; M A Nelson; G T Bowden
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  A high frequency of sequence alterations is due to formalin fixation of archival specimens.

Authors:  C Williams; F Pontén; C Moberg; P Söderkvist; M Uhlén; J Pontén; G Sitbon; J Lundeberg
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 4.  p53 and the pathogenesis of skin cancer.

Authors:  Cara L Benjamin; Honnavara N Ananthaswamy
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-15       Impact factor: 4.219

5.  Preneoplastic lesion growth driven by the death of adjacent normal stem cells.

Authors:  Dennis L Chao; J Thomas Eck; Douglas E Brash; Carlo C Maley; E Georg Luebeck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

Review 6.  Sunlight and skin cancer: another link revealed.

Authors:  K H Kraemer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

Review 7.  The contribution of epidermal stem cells to skin cancer.

Authors:  Michael J Gerdes; Stuart H Yuspa
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 8.  Modeling cutaneous squamous carcinoma development in the mouse.

Authors:  Phillips Y Huang; Allan Balmain
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-02       Impact factor: 6.915

9.  Genetically abnormal clones in histologically normal breast tissue.

Authors:  P S Larson; A de las Morenas; L A Cupples; K Huang; C L Rosenberg
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

10.  p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes.

Authors:  V A Tron; M J Trotter; L Tang; M Krajewska; J C Reed; V C Ho; G Li
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.